Has Judith Lavrich received payments from drug or device companies?

Yes. Drug and device makers reported $5,117 in general payments to Judith Lavrich across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Judith Lavrich did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Judith Lavrich come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Judith Lavrich

Pediatric Ophthalmology and Strabismus Specialist · Philadelphia, PANPI 1386603769

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.6%), food and beverage and gifts — rather than concentrated in one kind of arrangement. Amgen accounts for 67.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $3,160 and has fallen 91.9% since, to $255 in 2023.

$5,117in general payments, 2019–2025

Across 72 payments — averaging $71.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$3K
AbbVie$397
Johnson & Johnson Surgical Vision, Inc.$311
Alcon$229
Mallinckrodt Hospital Products Inc.$124
Aerie Pharmaceuticals, Inc.$121
plus $504 from 15 others

What the payments were for

Speaking & faculty fees$3,00059%
Food & beverage$2,07641%
Education$40%
Gifts$371%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	22	$3,431
AbbVie	18	$397
Johnson & Johnson Surgical Vision, Inc.	5	$311
Alcon	3	$229
Mallinckrodt Hospital Products Inc.	1	$124
Aerie Pharmaceuticals, Inc.	1	$121
Glaukos Corporation	1	$97
Merz North America, Inc.	1	$85
Galderma Laboratories, L.p.	4	$58
Bausch & Lomb, A Division Of Bausch Health US, LLC	3	$44
Sight Sciences, Inc.	1	$36
Kala Pharmaceuticals, Inc.	1	$23
Dompe US, Inc.	1	$22
Travere Therapeutics, Inc.	3	$20
Carl Zeiss Meditec AG	1	$19
Spark Therapeutics, Inc.	1	$19
Tearlab Corp	1	$18
Carl Zeiss Meditec, Inc.	1	$17
Bausch & Lomb Americas Inc.	1	$17
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$15
Eyevance Pharmaceuticals LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric ophthalmology and strabismus specialist providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Other pediatric ophthalmology and strabismus specialist in Philadelphia

Danielle SarloPhiladelphia$477
Amanda ElyHershey$5K
Eric PennockCranberry Twp$3K
Christianne SchoedelGettysburg$439
Marjan Imani FooladiPittsburgh$219
Preeti PatilPittsburgh$177
Lee KlombersLancaster$107
Meghal GagraniPittsburgh$99
Farid KalantaritarariPittsburgh$75
Jane HughesCranberry Twp$39

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →